Pentachlorophenol (PCP) is a pesticide that was once widely used for wood preservation.
Pentachlorophenol (PCP) is a pesticide that was once widely used for wood preservation. Major uses included commercial wood treatment in the lumber industry and slime control in the pulp and paper industry. The sodium salt of PCP (NaPCP) was also used in wood preservation as a sap stain control agent. Minor uses have included various nonindustrial applications as a herbicide, antimicrobial, and disinfectant.
From 1984 to 1988, the U.S. EPA issued a series of strict regulatory controls over the manufacture, use, and disposal of PCP (1) . Commercial pentachlorophenol had contained a variety of impurities induding higher chlorinated dibenzo-p-dioxins (CDDs) and chlorinated dibenzofurans (CDFs). One of these compounds, hexachlorodibenzo-p-dioxin (HxCDD), was found to be a carcinogen and reproductive toxin in laboratory animals (2) . Production of PCP in the United States ceased in 1992.
Acute poisoning by PCP in exposed workers produces a characteristic syndrome of hyperpyrexia caused by uncoupling of oxidative phosphorylation (3) . The chronic effects of exposure to PCP have been studied in PCP production workers (4) (5) (6) (7) (8) (9) (10) , PCP formulators (11) , wood treatment workers (12, 13) , sprayers (11) , and sawmill workers (1416) . Several studies have demonstrated that exposure to commercial PCP can produce chloracne (4, (8) (9) (10) 17, 18) . Some studies have observed irritant effects on the eyes and upper respiratory tract (4, 16) , peripheral sensory neuropathy (5, 10) , reversible renal impairment (12) , decreased bilirubin (8, 11) , increased serum glutamate dehydrogenase (GLDH) (6) , increased urinary excretion of porphyrins (10) , decreased hematocrit and white blood cell count (15) , and increased frequency of chromosome alterations in lymphocytes (7').
In 1986, Northwestern University conducted a comprehensive morbidity study of past and present workers at a chemical plant in southwestern Illinois who had been engaged in the production of PCP as well as lower chlorinated phenols and esters of chlorphenoxy acids. This plant was also a major producer of polychlorinated biphenyls (PCBs). The purpose of this study was to determine if workers who had been engaged in the production of PCP, chlorinated phenols, and chlorphenoxy acid esters suffered any long-term health effects as a result of their past exposure to these compounds and their CDD and CDF contaminants. The primary hypotheses of this study were that exposures to these compounds may be associated with chloracne, liver dysfunction, disorders of porphyrin metabolism, neurobehavioral disturbances, disorders of lipid metabolism, and peripheral neuropathy.
This paper presents the results of the analyses of general health status, chloracne, and porphyrin metabolism for the group of workers who had ever been engaged in the production of PCP ("ever PCP"). We also present the results of analyses for the subgroup of these workers who produced PCP but did not produce lower chlorinated phenols or esters of chlorphenoxy acids ("only PCP"), as well as the respective subgroups of workers with chloracne ("ever PCP, chloracne" and "only PCP, chloracne"). The results of analyses for the other exposure subgroups and effects on other organ systems will be presented in subsequent papers.
Materials and Methods
Plant history and process description. The chemical plant whose employees were examined in this study produced pentachlorophenol from 1938 Table 1 .
Description ofstudy populations. The exposed worker populations in this study were defined as all workers who were alive at the time of sample selection and who met one of the following definitions of exposure: 1) hourly production workers who had been engaged in the production of PCP for 3 or more days between 1938 and 1978; 2) hourly production workers who had been engaged in the production of monoand dichlorophenols between 1931 and 1983; 3) hourly production workers who had been engaged in could be missed by relying on this database alone. The plant medical department had maintained a registry of workers who were undergoing medical surveillance for chloracne beginning in 1970. Twenty-nine production workers on this chloracne registry who met the definition of exposure were included in the exposed group. Maintenance and other workers who were noted to have chloracne on these plant medical records, with the exception of workers who were exclusively engaged in the production of PCBs or chlorinated benzenes, were also induded as a separate exposure subgroup. These workers were included as a separate subgroup because, before 1983, personnel records did not specify the departmental assignments of maintenance workers.
The unexposed comparison population was defined as workers who had ever been employed at this same plant on The health status of participants was measured through a comprehensive medical examination that induded a complete medical and reproductive history, physical examinations, electrocardiogram, spirometry, chest X ray, quantitative sensory testing, neurobehavioral evaluation, and blood, urine, and saliva tests. Reported conditions were verified through a review of hospital, plant medical, and vital records. Obtainability rates for these records were 95% for birth records of offspring, 57% for medical records after date of first employment, and 50% for requested plant medical records. The majority of missing plant medical records were older, inactive files that had been archived and lost. All available records were reviewed and coded by trained record review technicians. All on-site data collection personnel, other than the medical interviewer administering the occupational and environmental history questionnaire, were blinded to the participants' exposure status. The interviewer who administered this questionnaire was not allowed to share any work history information with other examiners. Editing, reduction, and entry of all health outcome data were also done with the research staff blinded to the participants' exposure status. Medical history of chloracne was defined as a positive response to the question, "Did a doctor ever tell you that you had chloracne, which is a type of acne caused by chemicals?" on the medical history questionnaire. Participants were also asked to respond to the questions, "Has there ever been a time when your skin seemed unusually dark for you, even though you hadn't had excessive sun exposure?" and "Have you ever been bothered by excess hair growth?" Plant medical record chloracne was coded as positive if the O'Malley score (9) was 1-3 and negative if the score was 4-6.
Dermatologists were asked to rate to what extent the participant's examination was consistent with the diagnosis of chloracne on a five-point scale (1 = very unlikely to 5 = highly likely). Participants with scores of 4 or 5 were coded as positive for chloracne on dermatologic examination. Dermatologists were also asked to determine if participants had hyperpigmentation or hypertrichosis.
The history of porphyria was determined by asking participants, "Have you ever been told by a doctor that you had porphyria?" The history ofsymptoms suggestive of porphyria was determined by asking participants, "Have you ever had a medical condition in which you had unusual blistering of sun-exposed skin combined with dark, reddish urine?" Dermatologists were asked to rate on a five-point scale (1 =very unlikely to 5 = highly likely) the extent to which the participant's dermatologic examination was consistent with a diagnosis of porphyria cutanea tarda.
Each participant was asked to begin a 24-hr urine collection for quantitative porphyrins after providing a spot morning urine on the day of the examination. These samples were submitted to the Mayo Clinic for analysis. Urinary porphobilinogen was measured spectrophotometrically after complexation with Erlich's reagent by a modification of the method of Schwartz et al. (24) . Quantitative porphyrins were analyzed using high performance liquid chromatography (25 pack-years) than unexposed workers. The only PCP workers were also significantly older (59.7 years) and had lower household income than unexposed workers. PCP workers with chloracne (ever PCP, chloracne) were also significantly older (54.8 years) and had more pack-years of smoking (23.6 pack-years) compared to unexposed workers. The only PCP workers with chloracne had significantly less alcohol consumption (20.8 vs. 35 .8 ounces/month) than unexposed workers. There were no significant differences between any of the exposure groups and unexposed workers with regard to race.
General health. After adjusting for the effects of age, gender, race, years of schooling, and employment status, there were no significant differences between the unexposed group and any of the PCP exposure subgroups with respect to self-perception of health, self-reported hospitalizations over the past 12 months, or self-reported doctor/dinic visits over the past 12 months (data not shown). Ever PCP workers were more likely to report staying home due to illness over the past 12 months (adjusted OR = 1.47, p = 0.042), but there was no significant difference in the mean number of days they stayed at home due to illness (ever PCP 6.6 days vs. unexposed 4.9 days). There were no significant differences between the unexposed group and the ever PCP, chloracne or only PCP, chloracne subgroups with regard to these same general health indicators after adjustment. Also, there were no significant differences, either unadjusted or adjusted, between unexposed and any of the PCP exposure subgroups with regard to the internist's assessment of their general physical appearance.
Chloracne Penta-, hexa-, and hepta-log transformed; uro-and coproporphyrin and porphobilinogen not transformed.
bAbnormal for males defined as uro >46; hepta >13; hexa >5; penta >4; copro >96. Abnormal for females defined as uro >22; hepta >9; hexa >4; penta >3; copro >60. Abnormal porphobilinogen >2 for males and females. *0.01 <p <0.05; **p < 0.01 p<O.OOl) than the unexposed group in multivariable analysis.
Discussion
The purpose of this morbidity study was to determine if workers who had been engaged in the production of PCP suffered any longterm health effects as a result of their exposures to PCP and its CDD and CDF contaminants. The time since last exposure ranged from 8 to more than 30 years. As PCP has an elimination half-life of 30.2 hr (27), these workers were unlikely to have significant residual body burdens of PCP. Some CDDs and CDFs, however, have long elimination half-lives and appreciable levels can persist many years after exposure (28) . This study was designed to measure the prevalence of persistent effects years after exposure and not the incidence of reversible health effects during or shortly after exposure. Our primary hypotheses included those health effects that some investigators have reported in dioxin-exposed individuals many years after exposure, specifically chloracne (4, (8) (9) (10) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) , liver dysfunction (6, 20, 31, 33, 35, 39) , disorders of porphyrin metabolism (10, 35, 37, 40, 41) , neurobehavioral disturbances (35, 36, (42) (43) (44) (45) , disorders of lipid metabolism (32, 35, 43, 46, 47) , and peripheral neuropathy (4, 5, 10, 31, 35, 42, (48) (49) (50) (51) . The analyses in this paper focus on general health status, chloracne, and disorders of porphyrin metabolism.
In our study, 17.8% ofworkers who had ever been engaged in the production of PCP had evidence of chloracne by medical history, plant medical records, or dermatologic exam. Chloracne resolved in the majority of affected workers: only 11.3% of those who reported a doctor's diagnosis of chloracne still had chloracne at the time of dermatologic exam. The odds of developing chloracne increased with duration ofexposure.
O'Malley et al. (9) reviewed the plant medical records of workers who had been engaged in the production of PCP between 1951 and 1978 at this plant. Seven percent of the workers had evidence of chloracne on plant medical records, compared to 8.8% in our only PCP, chloracne group. O'Malley et al. did not find a significant trend between standardized incidence ratios of chloracne and duration of exposure. The differences in our results for trend between duration of exposure and chloracne may be due to differences in the selection of intervals for duration of exposure. We found a significant trend in the odds of developing chloracne during the first year of exposure using time intervals of 3-29, 30- Chloracne has also been observed in PCP production workers at other plants (4, 8, 10) and in a worker with prolonged exposure to PCP-treated wood (18) . Technical PCP has been shown to produce chloracne in a rabbit ear model, whereas pure PCP does not (52) .
Our PCP workers with chloracne had significantly elevated mean urinary excretions of coproporphyrin compared to the unexposed workers after control for potential confounders. There were no significant differences in the urinary excretion of uroporphyrins, and none of participants had a history of porphyria cutanea tarda. The pattern of porphyrin excretion in our workers with chloracne is consistent with subdinical, low-grade coproporphyrinuria.
Studies of porphyrin metabolism in TCDD-exposed individuals have yielded conflicting results. In the two plants where workers had clinical porphyria (35,3X), hexachlorobenzene may have been a confounding exposure (53). Calvert et al. (54) did not find significant associations between serum levels of TCDD and porphyria cutanea tarda, uroporphyrinuria, or coproporphyrinuria in a cohort of workers who had been exposed to chemicals contaminated with TCDD more than 15 years earlier.
Residents of Seveso have been found to have subdinical coproporphyrinuria compared to controls (41) . The only documented cases of porphyria cutanea tarda among Seveso residents occurred in a family with congenital uroporphorinogen decarboxylase (UROD) deficiency (40) .
Studies of PCP-exposed workers have also yielded conflicting results. Baxter (8) Table 1 . Potential porphyrinogens include the chlorinated dibenzodioxins and chlorinated dibenzofurans. An alternative explanation may be contamination of technical PCP with hexachlorobenzene. Although hexachlorobenzene was not measured in the PCP produced at this plant, an industry composite of technical-grade pentachlorophenol prepared from material supplied by three U.S. manufacturers contained low concentrations of hexachlorobenzene (50 ppm), which is a known porphyrinogen in humans (2). We were unable to test for statistical interaction between PCP and PCB exposure on urinary porphyrin excretion in our study because we did not have a separate study group exposed to PCBs alone.
Mean porphyrin levels in our unexposed group were higher than those of many, but not all, previous studies (60 (61) found that serum levels of 2,3,7,8-TCDD were related to duration of employment in workers engaged in the production of 2,4,5-trichlorophenol and 2,4,5-trichlorophenoxyacetic acid. Neuberger et al. (62) found higher serum levels of 2,3,7,8-TCDD in production workers with chloracne compared to unexposed referents, whereas Beck et al. (63) found little correlation between adipose PCDD or PCDF concentrations and incidence of chloracne in exposed workers. Chloracne may be a marker of both exposure and susceptibility in exposed workers.
A limitation inherent in the cross-sectional design is the use of prevalence rather than incidence as a measure of disease frequency. If exposure affects survival or ability to participate in the examination due to illness, then this could bias the results toward the null hypothesis. The long lag times between last exposure and time of medical examination limit our ability to study past events. Finally, the small numbers of individuals in our highest exposure groups (ever and only PCP, chloracne), limit our ability to detect significant differences due to low study power, and negative results should be interpreted with a consideration of the potential for beta error.
Despite these limitations, this is the largest morbidity study of pentachlorophenol production workers conducted to date and provides important information on the health status of workers with past exposure to PCP and its CDD and CDF contaminants. Overall, the general health status of these PCP-exposed workers was similar to unexposed workers. The major clinical effect we observed in PCP-exposed workers was chloracne. The other finding we believe is consistent with current knowledge of the effects of exposure to CDDs and CDFs is elevation in urinary excretion of coproporphyrins in persons with chloracne. The high urinary excretion of uro-, hepta-, penta-, and coproporphyrins among the subgroup of workers with chloracne who had worked with both PCP and PCBs suggests a possible interaction between compounds present in technical PCP and PCBs on porphyrin metabolism.
